Ali Ahmed, MD, Gregg C. Fonarow, MD, Yan Zhang, MS, MSPH, Paul W

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

The Epidemic of the 20th Century: Coronary Heart Disease

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD

Volume 146, Issue 5, Pages (November 2014)

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Manjula Kurella Tamura,

Beta blockers in the management of chronic kidney disease

Isolated Systolic Hypertension: An Update After SPRINT

Comparative Effectiveness Research and Medical Informatics

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole

Viper venom for diabetic nephropathy

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Manjula Kurella Tamura,

Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure Ali Ahmed, MD, MPH, Robert C. Bourge, MD,

Nancy M. Albert, PhD, Gregg C. Fonarow, MD, William T

Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial Yutao Guo,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Sayed H. Naderi, BMedSci, Jonathan P. Bestwick, MSc, David S. Wald, MD

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Overview of Current Learning Theories for Medical Educators

Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

Franz H. Messerli, MD, Sripal Bangalore, MD, MHA

NSAID Use and Progression of Chronic Kidney Disease

United States Counties with Low Black Male Mortality Rates

Membranous nephropathy: When and how to treat

Viper venom for diabetic nephropathy

Tick Tock The American Journal of Medicine

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review Elliot B. Tapper, MD, Alan Bonder,

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Michael A. Weber, MD, George L

Fig. 2. Evidence-based medication prescriptions

Acute Kidney Injury and Death Associated With Renin Angiotensin System Blockade in Cardiothoracic Surgery: A Meta-analysis of Observational Studies Rabi.

Nat. Rev. Cardiol. doi: /nrcardio

The Impact of Prior Heart Failure Hospitalizations on Long-term Mortality Differs by Baseline Risk of Death Naga V.A. Kommuri, MD, Todd M. Koelling,

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical.

Polyunsaturated Fatty Acids and Kidney Disease

Impact of Resident Workload and Handoff Training on Patient Outcomes

Study Designs in Patient-Oriented Research

Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S

Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction Marjan Mujib, MD, MPH, Kanan Patel, MBBS, MPH,

Effect of Spironolactone on Physical Performance in Older People with Self-reported Physical Disability Louise A. Burton, MD, Deepa Sumukadas, MD, Miles.

Rami Doukky et al. JCHF 2016;4:24-35

Sarah C. Snow, MD, Gregg C. Fonarow, MD, Joseph A

Effect of Renin-Angiotensin System Blockade on Calcium Channel Blocker-Associated Peripheral Edema Harikrishna Makani, MD, Sripal Bangalore, MD, MHA,

Statin Use and Risk of COPD Exacerbation Requiring Hospitalization

Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

George L. Bakris, MD, John M. Burkart, MD, Eric D

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure Cherinne Arundel,

Isolated Systolic Hypertension: An Update After SPRINT

Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter? Dimitris Mavridis, PhD American Journal.

Volume 73, Issue 5, Pages (March 2008)

Juan Jesús Carrero, PhD American Journal of Kidney Diseases

Has mortality from acute renal failure decreased

β-Blocker Use for the Stages of Heart Failure

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Presentation transcript:

Renin-Angiotensin Inhibition in Systolic Heart Failure and Chronic Kidney Disease Ali Ahmed, MD, Gregg C. Fonarow, MD, Yan Zhang, MS, MSPH, Paul W. Sanders, MD, Richard M. Allman, MD, Donna K. Arnett, PhD, Margaret A. Feller, MPH, Thomas E. Love, PhD, Inmaculada B. Aban, PhD, Raynald Levesque, MS, O. James Ekundayo, MD, DrPH, Louis J. Dell'Italia, MD, George L. Bakris, MD, Michael W. Rich, MD The American Journal of Medicine Volume 125, Issue 4, Pages 399-410 (April 2012) DOI: 10.1016/j.amjmed.2011.10.013 Copyright © 2012 Terms and Conditions

Figure 1 Absolute standardized differences comparing 56 baseline characteristics of older patients with systolic heart failure and chronic kidney disease receiving and not receiving discharge prescription of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, before and after propensity score matching. The American Journal of Medicine 2012 125, 399-410DOI: (10.1016/j.amjmed.2011.10.013) Copyright © 2012 Terms and Conditions

Figure 2 Kaplan–Meier plots for all-cause mortality in a propensity-matched cohort of older patients with systolic heart failure with chronic kidney disease receiving and not receiving discharge prescription of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs). CI=confidence interval. The American Journal of Medicine 2012 125, 399-410DOI: (10.1016/j.amjmed.2011.10.013) Copyright © 2012 Terms and Conditions

Figure 3 Association of discharge prescription of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) with all-cause mortality in subgroups of propensity-matched older patients with systolic heart failure with chronic kidney disease. BP=blood pressure; CI=confidence interval; EF=ejection fraction; GFR=glomerular filtration rate. The American Journal of Medicine 2012 125, 399-410DOI: (10.1016/j.amjmed.2011.10.013) Copyright © 2012 Terms and Conditions